Frequency, Predictors, and Economic Impact of Upward Dose Adjustment of Infliximab in Managed Care Patients With Rheumatoid Arthritis

OBJECTIVES: To examine dosing patterns and costs among rheumatoid arthritis (RA) patients newly treated with infliximab in a large national health care claims database. METHODS: Using data from a proprietary database of pharmacy and medical claims for 75 U.S. health plans, RA patients newly treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollendorf, Daniel A., Massarotti, Elena, Birbara, Charles, Burgess, Somali Misra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438098/
https://www.ncbi.nlm.nih.gov/pubmed/15934797
http://dx.doi.org/10.18553/jmcp.2005.11.5.383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438098/
https://www.ncbi.nlm.nih.gov/pubmed/15934797
http://dx.doi.org/10.18553/jmcp.2005.11.5.383

Ejemplares similares